MEDICAL UPDATE: Clarification on Intramuscular Pentamidine
Being Alive Newsletter, Being Alive/Los Angeles - June 1993 Mark Katz, MD and reported by Jim Stoecker
In the January update, reported in the March Newsletter, we discussed a study at Mount Sinai in New York that used intramuscular pentamidine as PCP prophylaxis. Apparently we did not make it clear that, at the present time, this is an experimental regimen only. It has not by any means become a standard of care. As we reported, this approach to PCP prophylaxis holds promise for those intolerant of Bactrim/Septa, but further study is needed to assess intramuscular pentamidine's effectiveness and cumulative safety.
930600
BA930606
AEGiS is made possible through unrestricted grants from Roxane Laboratories, the National Library of Medicine, and donations from users like you. Always watch for outdated information. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.
This information is designed to support, not replace, the relationship that exists between you and your doctor.